|
1
|
Raghu G, Remy-Jardin M, Myers JL, Richeldi
L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F,
et al: Diagnosis of idiopathic pulmonary fibrosis. An official
ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care
Med. 198:e44–e68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Richeldi L, Collard HR and Jones MG:
Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wolters PJ, Collard HR and Jones KD:
Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol.
9:157–179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Legler DF and Thelen M: Chemokines:
Chemistry, biochemistry and biological function. Chimia (Aarau).
70:856–859. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liekens S, Schols D and Hatse S:
CXCL12-CXCR4 axis in angiogenesis, metastasis and stem cell
mobilization. Curr Pharm Des. 16:3903–3920. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li J, Li T, Li S, Xie L, Yang YL, Lin Q,
Kadoch O, Li H, Hou S and Xu Z: Experimental study of the
inhibition effect of CXCL12/CXCR4 in malignant pleural
mesothelioma. J Investig Med. 67:338–345. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miller RJ, Banisadr G and Bhattacharyya
BJ: CXCR4 signaling in the regulation of stem cell migration and
development. J Neuroimmunol. 198:31–38. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He W, Yang T, Gong XH, Qin RZ, Zhang XD
and Liu WD: Targeting CXC motif chemokine receptor 4 inhibits the
proliferation, migration and angiogenesis of lung cancer cells.
Oncol Lett. 16:3976–3982. 2018.PubMed/NCBI
|
|
9
|
Bagnato G and Harari S: Cellular
interactions in the pathogenesis of interstitial lung diseases. Eur
Respir Rev. 24:102–114. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips RJ, Burdick MD, Hong K, Lutz MA,
Murray LA, Xue YY, Belperio JA, Keane MP and Strieter RM:
Circulating fibrocytes traffic to the lungs in response to CXCL12
and mediate fibrosis. J Clin Invest. 114:438–446. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mehrad B, Burdick MD and Strieter RM:
Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary
fibrosis. Int J Biochem Cell Biol. 41:1708–1718. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Xu J, Mora A, Shim H, Stecenko A, Brigham
KL and Rojas M: Role of the SDF-1/CXCR4 axis in the pathogenesis of
lung injury and fibrosis. Am J Respir Cell Mol Biol. 37:291–299.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Makino H, Aono Y, Azuma M, Kishi M, Yokota
Y, Kinoshita K, Takezaki A, Kishi J, Kawano H, Ogawa H, et al:
Antifibrotic effects of CXCR4 antagonist in bleomycin-induced
pulmonary fibrosis in mice. J Med Invest. 60:127–137. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kleaveland KR, Velikoff M, Yang J, Agarwal
M, Rippe RA, Moore BB and Kim KK: Fibrocytes are not an essential
source of type I collagen during lung fibrosis. J Immunol.
193:5229–5239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barbero S, Bonavia R, Bajetto A, Porcile
C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and
Schettini G: Stromal cell-derived factor 1alpha stimulates human
glioblastoma cell growth through the activation of both
extracellular signal-regulated kinases 1/2 and Akt. Cancer Res.
63:1969–1974. 2003.PubMed/NCBI
|
|
16
|
Wang X, Cao Y, Zhang S, Chen Z, Fan L,
Shen X, Zhou S and Chen D: Stem cell autocrine CXCL12/CXCR4
stimulates invasion and metastasis of esophageal cancer.
Oncotarget. 8:36149–36160. 2017.PubMed/NCBI
|
|
17
|
Guo S, Xiao D, Liu H, Zheng X, Liu L and
Liu S: Interfering with CXCR4 expression inhibits proliferation,
adhesion and migration of breast cancer MDA-MB-231 cells. Oncol
Lett. 8:1557–1562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abraham M, Klein S, Bulvik B, Wald H,
Weiss ID, Olam D, Weiss L, Beider K, Eizenberg O, Wald O, et al:
The CXCR4 inhibitor BL-8040 induces the apoptosis of AML blasts by
downregulating ERK, BCL-2, MCL-1 and cyclin-D1 via altered
miR-15a/16-1 expression. Leukemia. 31:2336–2346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Wan X, Geng J, Li F, Wang C and Dai
H: Kinase inhibitors fail to induce mesenchymal-epithelial
transition in fibroblasts from fibrotic lung tissue. Int J Mol Med.
32:430–438. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang J, Li Z, Yao X, Li Y, Reng X, Li J,
Wang W, Gao J, Wang C, Tankersley CG and Huang K: Altered Th1/Th2
commitment contributes to lung senescence in CXCR3-deficient mice.
Exp Gerontol. 48:717–726. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ashcroft T, Simpson JM and Timbrell V:
Simple method of estimating severity of pulmonary fibrosis on a
numerical scale. J Clin Pathol. 41:467–470. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shimizu Y, Dobashi K, Endou K, Ono A,
Yanagitani N, Utsugi M, Sano T, Ishizuka T, Shimizu K, Tanaka S and
Mori M: Decreased interstitial FOXP3(+) lymphocytes in usual
interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis. Int J
Immunopathol Pharmacol. 23:449–461. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Buck AK, Stolzenburg A, Hänscheid H,
Schirbel A, Lückerath K, Schottelius M, Wester HJ and Lapa C:
Chemokine receptor-directed imaging and therapy. Methods.
130:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Balkwill F: Chemokine biology in cancer.
Semin Immunol. 15:49–55. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Balkwill F: The significance of cancer
cell expression of the chemokine receptor CXCR4. Semin Cancer Biol.
14:171–179. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dai Z, Li M, Wharton J, Zhu MM and Zhao
YY: Prolyl-4 Hydroxylase 2 (PHD2) deficiency in endothelial cells
and hematopoietic cells induces obliterative vascular remodeling
and severe pulmonary arterial hypertension in mice and humans
through hypoxia-inducible factor-2α. Circulation. 133:2447–2458.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dai Z, Zhu MM, Peng Y, Jin H, Machireddy
N, Qian Z, Zhang X and Zhao YY: Endothelial and smooth muscle cell
interaction via FoxM1 signaling mediates vascular remodeling and
pulmonary hypertension. Am J Respir Crit Care Med. 198:788–802.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Andersson-Sjöland A, de Alba CG, Nihlberg
K, Becerril C, Ramírez R, Pardo A, Westergren-Thorsson G and Selman
M: Fibrocytes are a potential source of lung fibroblasts in
idiopathic pulmonary fibrosis. Int J Biochem Cell Biol.
40:2129–2140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mehrad B, Burdick MD, Zisman DA, Keane MP,
Belperio JA and Strieter RM: Circulating peripheral blood
fibrocytes in human fibrotic interstitial lung disease. Biochem
Biophys Res Commun. 353:104–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lin CH, Shih CH, Tseng CC, Yu CC, Tsai YJ,
Bien MY and Chen BC: CXCL12 induces connective tissue growth factor
expression in human lung fibroblasts through the Rac1/ERK, JNK, and
AP-1 pathways. PLoS One. 9:e1047462014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tian Y, Yin H, Deng X, Tang B, Ren X and
Jiang T: CXCL12 induces migration of oligodendrocyte precursor
cells through the CXCR4-activated MEK/ERK and PI3K/AKT pathways.
Mol Med Rep. 18:4374–4380. 2018.PubMed/NCBI
|
|
32
|
Penke LR, Speth JM, Dommeti VL, White ES,
Bergin IL and Peters-Golden M: FOXM1 is a critical driver of lung
fibroblast activation and fibrogenesis. J Clin Invest.
128:2389–2405. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rock JR, Barkauskas CE, Cronce MJ, Xue Y,
Harris JR, Liang J, Noble PW and Hogan BL: Multiple stromal
populations contribute to pulmonary fibrosiswithout evidence for
epithelial to mesenchymal transition. Proc Natl Acad Sci USA.
108:E1475–E1483. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie T, Liang J, Liu N, Huan C, Zhang Y,
Liu W, Kumar M, Xiao R, D'Armiento J, Metzger D, et al:
Transcription factor TBX4 regulates myofibroblast accumulation and
lung fibrosis. J Clin Invest. 126:3063–3079. 2016. View Article : Google Scholar : PubMed/NCBI
|
